Browse studies

Find your next paid study

29 recruiting studies matching your filters

Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder

This is a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial evaluating the tolerability, safety, and preliminary efficacy of tirzepat…

Methamphetamine Use Disorder

Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT07825857

Observational

The Use of Repetitive Transmagnetic Stimulation to Target Craving in Methamphetamine Use Disorder

The primary aim of this project is to use a randomized single-blind sham-controlled study to investigate if high frequency repetitive transmagnetic stimulation…

Methamphetamine AbuseSubstance Use DisordersStimulant Dependence+3 more

Estimated

~$10 – $6,250

Oregon Health and Science UniversityNCT03470480

Phase 2

Psilocybin in the Treatment of Methamphetamine Use Disorder

This trial tests whether psilocybin-assisted treatment can help adults stop using methamphetamine. Participants receive a single oral dose of psilocybin during…

Methamphetamine Use Disorder

Estimated

~$10 – $7,500

Peter HendricksNCT07774702

Phase 1

The Low-Down on Methamphetamine Isomers: Prevalence and Pharmacology in Humans

This study is being done to understand the metabolism and impairment profile of methamphetamine (meth). Meth exists as two chemical structures that are mirror …

Methamphetamine

Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT06746831

Observational

CHAMPION: Combining HIV And Meth Prevention and Treatment Interventions Optimized for HIV-Negative MSM

The goal of this randomized controlled trial is to pilot test new mobile health (mHealth) interventions to improve PrEP adherence among HIV-negative men who ha…

PrEP AdherenceMethamphetamine Use DisorderHIV

Estimated

~$10 – $6,250

University of California, San DiegoNCT07213258

Phase 4

Short-term Effects of Methamphetamine on Residual Latent HIV Disease (EMRLHD) Study

The most commonly used illicit stimulant in people with HIV (PWH) is methamphetamine (MA). Prior studies demonstrate strong evidence that MA promotes increased…

HIV -1 InfectionMethamphetamine Use

Estimated

~$10 – $5,625

University of California, San FranciscoNCT07584369

Phase 2

Psilocybin Recovery Intervention for Stopping Methamphetamine Use

The goal of this clinical trial is to learn whether it is possible to use psilocybin in combination with motivational support therapy to treat moderate-to-seve…

Methamphetamine Use DisorderHuman Immunodeficiency Virus (HIV)

Estimated

~$10 – $7,500

Nicky Mehtani, MD, MPHNCT07756736

Phase 2

An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder Using fMRI to Identify Novel Neural Biomarkers

This open label pilot study will assess the feasibility and preliminary efficacy of tirzepatide which will be prescribed under its FDA approved weight manageme…

ObesityMethamphetamine Use DisorderCocaine Use Disorder+1 more

Estimated

~$10 – $6,250

University of Texas Southwestern Medical CenterNCT07693608

Phase 2

A Phase 2 Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants With Methamphetamine Use Disorder Not Seeking Treatment Receiving a Single Dose of Methamphetamine

The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infus…

Methamphetamine IntoxicationMethamphetamine DisordersMethamphetamine Abuse

Estimated

~$10 – $8,750

Clear Scientific, Inc.NCT06721494

Phase 2

Glutide for Ending Methamphetamine

GEM is a two-phase study to evaluate the use of semaglutide (Wegovy) for the treatment of methamphetamine use disorder (MeUD). The first phase is a pilot stud…

Methamphetamine-dependence

Estimated

~$10 – $5,625

San Francisco Department of Public HealthNCT07204249

Phase 1

Advancing Troiluzole as a Treatment for Methamphetamine Use Disorder: A Human Laboratory Study

This will be a human laboratory study evaluating the influence of troriluzole treatment on the effects of methamphetamine. Supported by and included in the Hel…

Methamphetamine Use Disorder

Estimated

~$10 – $7,500

William StoopsNCT06989853

Observational

Advancing Non-Abstinence Outcomes in the Treatment of Methamphetamine Use Disorder

Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral c…

Methamphetamine Use Disorder

Estimated

~$10 – $7,500

William StoopsNCT07226596